15h
Money Talks News on MSNNo Doctor Needed: FDA Greenlights Self-Administered Flu VaccineThis nasal spray vaccine can be self-administered or given by a caregiver, potentially increasing vaccination rates and ...
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.
PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions ... he’s attempted just about everything to manage it, to no avail. “I kind of just felt stuck and ...
But after one year, he leased three of the 11 ponds to his wife Afrin Taposh for 2 years. However, during the on-site inspection, the ACC found that apart from the three ponds, no other ponds existed ...
Learn more. Nasal decongestant spray can help relieve sinus infection symptoms in the short term. But you should limit your use to no more than 3 days to avoid a rebound effect, which can lead to ...
In the study, scientists used a spray. Nasal vestibulitis is not usually an emergency. However, if a person with a weakened immune system develops a fever, they should go to the emergency room ...
If the water is still running and no pipes have burst, you can take the following steps. (Of course, if you suspect a more serious problem, call a plumber.) Turn on the faucet. As you heat the ...
Johnson & Johnson's nasal spray received US FDA approval The nasal spray is used for the treatment of major depressive disorder The drug brought in sales of $780 million in 2024 The US Food and Drug ...
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...
Got a tip? Send it to The Daily Beast here. ADVERTISEMENT ADVERTISEMENT ...
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results